期刊文献+

老年人食管鳞状细胞癌、腺癌和化生-不典型增生-腺癌微卫星改变

Microsatellite Alterations in Elderly Patients with Esophageal Squamous Cell Carcinoma, Adenocarcinoma or Metaplasia-Dysplasia-Adenocarcinoma Sequence
下载PDF
导出
摘要 目的评估老年人食管鳞状细胞癌(ESCC)、食管腺癌(EADC)和Barrett化生-不典型增生-腺癌序列DNA微卫星的改变。方法应用稀释性PCR技术检测老年人ESCC、EADC和Barrett化生-不典型增生-腺癌序列中D2S123、D3S1616、D3S1300、BATRII、D5S346、D17S787和D18S617个位点DNA微卫星的改变。结果在非稀释DNA中,23例老年人ESCC和18例老年人EADC微卫星不稳定性(MSI)的频率分别是47.8%(11/23例)和38.9%(7/18例),杂合性丢失(LOH)的频率分别是26.1%(6/23例)和16.7%(3/18例),两者的MSI或LOH频率比较没有显著差别(P>0.05)。在稀释DNA中,8例老年人正常食管鳞状上皮和Barrett化生-异型增生-腺癌序列的MSI和LOH频繁出现,尤其在D3S1616、D2S123、D3S1300和D17S787位点上,与非稀释DNA的MSI和LOH频率相比有显著差别(P<0.05)。结论老年人ESCC和EADC微卫星改变没有差别。老年人正常食管鳞状上皮和Barrett化生-异型增生-腺癌组织DNA的MSI和LOH普遍存在,它们可能是EADC发生发展的早期分子事件,D3S1616、D2S123、D3S1300和D17S787位点的微卫星改变可能在此过程中起着重要作用。 Objective To assess microsatellite alterations in elderly patients with esophageal squamous cell carcinoma(ESCC), esophageal adenocarcinoma(EADC) and metaplasia dysplasia adenocarcinoma sequence. Methods Microsatellite analysis were evaluated at D2S123, D3S1616, D3S1300, BATRII, D5S346, D17S787, and D18S61 loci. The occurence of microsatellite instability(MSI) and rates of loss of heterozygosity(LOH) was detected in elderly patients with ESCC, EADC and metaplasia dysplasia adenocarcinoma sequence. Results The rates of MSI are 47.8%(11/23 cases) and 38.9%(7/18 cases) at undilution DNA in 23 cases ESCC and 18 cases EADC. The rates of LOH are 26. 1%0(6/23 cases) and 16.7%(3/18 cases) at undilution DNA in ESCC and EADC. There are not statistically significant differences in the rates of MSI and LOH at above 7 loci at undilution DNA between ESCC and EADC(P〉0.05). The rates of MSI and LOH at above 7 loci are frequent at dilution DNA in 8 cases normal esophageal squamous epithelia and metaplasia dysplasia adenocarcinoma sequences, especially at D3S1616, D2S123, D3S1300 and D17S787 loci. There are statistically significant differences in the rates of MSI and LOH between dilution DNA and undilution DNA. Conclusion There are not differences in the rates of MSI and LOH between ESCC and EADC in elderly patients. High level rates of MSI and LOH are common at dilution DNA in elderly patients with normal esophageal squamous epithelium and metaplasia dysplasia adenocarcinoma sequence. The MSI and LOH may be a early genetic events during esophageal carcinogenesis.
出处 《福建医科大学学报》 2007年第2期109-113,共5页 Journal of Fujian Medical University
基金 厦门市科技基金资助项目(3502Z20052018) 厦门市卫生局重点科研基金资助项目(WSK0301)
关键词 鳞状细胞 食管肿瘤 腺癌 微卫星重复 聚合酶链反应 BARRETT食管 化生 增生 序列分析 Cai Jianchun, Liu Di, Liu Kaihua, Zhang Haiping, Zhong Shan, Xia Ningshao(1. Department of Oncology Surgery, Xiamen Cancer Center, The Affiliated Xiamen First Hospital, Fujian Medical University, Xiamen 361003, China 2. Chemistry and Chemical Engineering College, Xiamen University, Xiamen 361005, China 3. National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Fujian Province Institute of Medically Molecular Virology, Xiamen 361005, China) carcinoma,squamous cell esophageal neoplasms adenocarcinoma microsatellite repeats barrett esophagus metaplasis hyperplasia
  • 相关文献

参考文献13

  • 1Romagnoli S,Roncalli M,Graziani D,et al.Molecular alterations of barrett's esophagus on microdissected endoscopic biopsies[J].Lab Invest,2001,81:241-247.
  • 2Rossi M,Barreca M,de Bortoli N,et al.Efficacy of Nissen fundoplication versus medical therapy in the regression on low-grade dysplasia in patients with barrett esophagus[J].Ann Surg,2006,243:58-63.
  • 3郑松柏,项平,徐富星,欧平安.老年人反流性食管炎1119例分析[J].中华老年医学杂志,2005,24(8):574-576. 被引量:58
  • 4Tselepis C,Morris C D,Wakelin D,et al.Upregulation of the oncogene in Barrett's adenocarcinoma:induction of c-myc by acidified bile acid in vitro[J].Gut,2003,52:174-180.
  • 5Walch A K,Zitzelsberger H F,Bruch J,et al.Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dyspasia-carcinoma sequence[J].Am J Pathol,2000,156:555-566.
  • 6林晴,王雯.环氧合酶-2表达与Barrett食管及食管腺癌的相关性[J].福建医科大学学报,2006,40(1):26-29. 被引量:2
  • 7Walch A K,Zitzelsberger H F,Bink K,et al.Molecular genetic changes in metastatic primary Barrett's adenocarcinoma and related lymph node metastases:comparison with nonmetastatic Barrett's adenocarcinoma[J].Mod Pathol,2000,13:814-824.
  • 8Kulke M H,Thakore K S,Thomas G,et al.Microsatellite instability and hMLH1/hMSH2 expression in Barrett esophagus-associated adenocarcinoma[J].Cancer,2001,91:1451-1457.
  • 9Yanagi M,Keller G,Mueller J,et al.Comparison of loss heterozygosity and microsatellite instability in adenocarcinomas of distal esophagus and proximal stomach[J].Virchows Arch,2000,437:605-610.
  • 10Falkenback D,Johansson J,Halvarsson B,et al.Defective mismatch-repair as a tumorigenic pathway in Barrett esophagus-associated adenocarcinomas[J].Cancer Genetics Cytogenetics,2005,157:82-86.

二级参考文献19

  • 1Streitz J J,Ellis FJ,Gibb SP,et al.Adenocarcinoma in Barrett's esophagus:a clinicopathologic study of 65 cases[J].Ann Surg,1991,213:122-125.
  • 2Mann NS,Tsai MF,Nair PK.Barrett' s esphagus in patiens with symptomatic reflux esphagitis[J].Am J Gastroenterol,1989,84:1494-1496.
  • 3Buttar NS,Kenneth KW,Leontovich O,et al.Chemoprevention of esophageal adencarcinoma by COX-2 inhibitors in an animal model of Barrett' s esophagus[J].Gastroenterology,2002,122:1101-1112.
  • 4Shirvani VN,Ouatu-Lasdar R,Kaur BS,et al.Cyclooxygenase-2 expression in Barrett' s esophagus and adenocarcinoma:ex vivo induction by bile salts and acid exposure[J].Gastroenterology,2000,118:487-496
  • 5Buttar NS,Anderson MA,Krishnadath KK,et al.Chemoprevention potiential of selective cyclooxygenase-2 (COX-2) inhibition in Barrett's esophagus epithelium:An in vitro study[J].Gastroenterology,2000,118:2.
  • 6Morris CD,Armstrong GR,Bogley G,et al.Cyclooxygenase-2 expression in Barrett' s metaplasia-dysplasia-adenocarcinoma sequence[J].Am J Gastroenterology,2001,96:990-996.
  • 7Van Rees BP,Saukkonen K,Rostimaki A,et al.Cyclooxygenase-2 expression during carcinogenesis in the human stomach[J].J Pathol,2002,196:171-179.
  • 8Buskens CJ,VanRees BP,Sivula A,et al.Prognostic significande of elevated cyclooxygenase-2 expression in patients with adenocarcinoma of the esophagus[J].Gastroenterology,2002,122:1800-1807.
  • 9Bailey T,Biddlestone L,Shepherd N,et al.Altered cadherincomplexes in the Barrett' s esophagus-dysplasia-adenocarcinoma sequence:Correlation with disease progression and differentiation[J].AmJPathol,1998,152:135-144.
  • 10Baljeet SK,Niloufar K,Mohamed I,et al.Rofecoxib inhibits cyclooxygenase-2 expression and reduces cell proliferation in Barrett's esophagus[J].Gastroenterology,2002,123:60-67.

共引文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部